StimLabs, a regenerative technology company announced that the first patient has been enrolled in the company’s clinical trial assessing the
The Centers for Disease Control reports that 15 percent of Americans living with type 2 diabetes struggle with hard-to-heal foot ulcers. Now, a
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: